Contactless Health Monitoring Device Can Assess Disease Risk
NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.
Read MorePosted by Chris Wolski | Nov 18, 2022 | Diabetes & Metabolic Diseases |
NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.
Read MorePosted by Andy Lundin | Nov 17, 2022 | Cardiovascular |
Clinicians who were high adopters of AI-enabled clinical decision support tools efficiently diagnosed low left ventricular ejection fraction.
Read MorePosted by Andy Lundin | Nov 16, 2022 | Prenatal Testing |
Sera Prognostics’ blood-based test offers individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Diagnostic Technologies |
Clinical laboratory experts predict continued importance on COVID testing, ongoing technician shortages, and more in 2023.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Immunoassay Reagents & test Kits |
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read More